Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: JAMA

Abbreviated Title: JAMA

Publisher: American Medical Association (AMA)

ISSN (Print): 0098-7484

Publication date (Electronic): February 12 2021

Affiliations

[1 ]Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

[2 ]Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Article

DOI: 10.1001/jama.2021.1967

PMC ID: 8890485

PubMed ID: 33576785

SO-VID: 42749319-ca10-4a90-b37f-63d53fd7ba6d

History

Data availability:

Comments

Comment on this article

scite_

Cited by 202

See all cited by

- Version 1